I was particularly interested by Dr Gordon's very acute Personal Paper because I was responsible for the RSM publications in the days when the Society used to work with a publishing partner.
While agreeing with almost all the advice he gives, I want to add one perception of my own. To my mind perhaps the most important discussion between would-be author and potential publisher is to make sure that both parties are on the same wavelength over whom the book is intended for. Is it for beginning students, graduate students, fellow clinicians or likely to be bought by libraries only? There is nothing inappropriate about discussing the competition and what the price will have to be if your book is to be bought. The price is often crucial.
I would strongly advise all authors to make sure they have a clear idea of the level for which they are writing and make sure that the publisher is in accord. It is not unreasonable to ask for an addendum to the contract setting out the agreed position. Editors come and go and publishing houses are bought and sold; something ®rm on paper will make sure that, even if the worst is threatened, the author can withdraw the ®nished manuscript and offer it elsewhere.
Anthony Watkinson
14 Park Street, Bladon, Woodstock, Oxon OX20 1RW, UK
It is appropriate that you should have published advice from a surgeon in North America. I have submitted two proposals in past years to different publishers for a book on the early management of spinal and spinal cord injury. There certainly is a gap on the shelves which this book would ®ll. After initial encouragement, which resulted in considerable preparatory work on my part, both proposals were rejected. The reasons given were similar: I am not con®dent that we could sell such a book successfully, particularly in North America. As I am sure you understand, we do depend heavily on this market for sales of our more specialised books.' (Churchill Livingstone, 1986) Our sales and marketing staff did not feel that there would be suf®cient interest in the book outside the UK and this would restrict the print run to an uneconomical level.' (Butterworth Heinemann, 1992) Sadly it seems that British medical practice must be dictated by the North American market, and therefore by medical practice in North America, this despite the facts that both patient expectations and responses to diseases and their treatment, and the economics of medical practice, differ greatly in that continent from those in the British Isles.
R G Pringle
Burnell House, 82 Berwick Road, Shrewsbury SY1 2NF, UK Dr Gordon provides an excellent summary of the practical issues facing those who set out to write a book. The subject will have a further airing at the RSM's Millennium Members Day on 7 July, when I am to give a short talk on how to get a book published. I hope that existing authors will join us to share their experience and advice.
Peter Richardson

Director of Publications,
The Royal Society of Medicine, London W1M 8AE, UK
Antithrombotic therapy in atrial ®brillation
Dr Adhiyaman and colleagues report underutilization of antithrombotic therapy in atrial ®brillation (March 2000 JRSM, pp 138±40). Adjusted-dose warfarin reduces risk for stroke by about 60% compared with placebo, aspirin reduces the risk (primarily for noncardioembolic ischaemic strokes which are less disabling than cardioembolic ischaemic strokes in atrial ®brillation) by about 20% compared with placebo, and warfarin reduces the risk by about 40% compared with aspirin 1 . Contrary to conventional wisdom, elderly patients with paroxysmal (41 episode) atrial ®brillation seem to have a risk for stroke similar to that of patients with sustained (persistent/ permanent) atrial ®brillation 1 .
Our hospital participated in the National Sentinel Clinical Audit of Evidence Based Prescribing for Older People conducted by the Royal College of Physicians, London. One arm of the audit was to assess use of
M a y 2 0 0 0 antithrombotics for patients with atrial ®brillation. Prescribing was considered appropriate if aspirin 300 mg was used in patients with contraindication to warfarin. Nationally 50% of the sample of patients in atrial ®brillation were not on warfarin or 300 mg aspirin. As with the paper by Adhiyaman et al., the data pointed to underutilization of antithrombotics 2 . Did they look at aspirin dosage? There is wide variation in the recommended dose (75±300 mg) for patients in atrial ®brillation. Selection of 300 mg as the appropriate dose of aspirin in the National Sentinel Clinical Audit was based on two reviews published subsequent to the Stroke Prevention in Atrial Fibrillation trial. I agree with the authors that if a prescriber judges that a given individual should not receive antithrombotics, that decision should be justi®ed and clearly recorded in the patient's notes.
The key message derived from these audits should be conveyed to junior doctors, nurses and pharmacists; and, if the underutilization of antithrombotics in atrial ®brillation is to be remedied, this education will need to be continuous because of the recurrent changes in junior staff at the frontline. We fully agree with Dr Adiyaman and colleagues that guidelines on antithrombotic therapy for atrial ®brillation (AF) are commonly disregarded in clinical practice and that this is most apparent in elderly patients with AF, in whom the bene®ts are potentially greatest 1 . Indeed, the elderly are underrepresented in the randomized trials of thromboprophylaxis in AF, and in one trial the rate of intracranial haemorrhage on warfarin nearly offset the bene®cial reduction in thromboembolic stroke 2 . In view of the concerns over anticoagulation for AF in the elderly, the consensus conference on AF by the Royal College of Physicians of Edinburgh proposed a target international normalized ratio (INR) range of 1.6 to 2.5 for elderly patients with AF aged 475 years, to provide substantial yet partial thromboprophylaxis ef®cacy with minimal bleeding risk 3 . However, this strategy has not been validated in any prospective randomized controlled trial. In fact, measure-ment of plasma prothrombin activation fragment F1-2, which provides a better index of in-vivo thrombin generation than INR, has shown levels to be signi®cantly higher in older patients with AF than in younger patients despite anticoagulation to equivalent INR values 4 . This study perhaps suggests that elderly patients should be anticoagulated to an even higher INR than younger patients, but at least to a target INR range validated to be bene®cial (that is, an INR of 2±3). The aim must be an acceptable balance between the risk of bleeding and the bene®t of preventing thromboembolic strokes. Since attempts at using lowintensity or ®xed-minidose warfarin, or even aspirin± warfarin combinations, have been unsuccessful, we are left with a strategy of providing thromboprophylaxis based on risk strati®cation, so that the highest-risk patients are identi®ed and targeted for anticoagulation 5 . Most risk strati®cation can be performed on clinical grounds, with some re®nement from echocardiography in cases of uncertainty.
S A Kausar
Dr Adhiyaman and colleagues also do not fully address the issue of what to do with paroxysmal AF patients, whose risk of stroke is similar to that of patients in chronic AF 6 . The range of stroke risk is likely to be wide, since a patient with a short paroxysm of AF once a year is likely to be at different risk from a patient with prolonged daily paroxysms 7 . Patients aged 475 years with paroxysmal AF who have clinical risk factors or structural heart disease are likely to be at high risk 7 . We recently cared for a patient quite similar to the one reported: 67 years old, she was referred to me with rapidly enlarging varicose veins said to have begun some 4 years previously after the right femoral artery had been used for cardiac catheterization performed in preparation for coronary artery bypass grafting. She had aching discomfort localized to her varicosities and had bled from a varix a few weeks before being seen. Although she was referred with a known diagnosis of tricuspid regurgitation documented by echocardiography, her pulsatile liver edge was not initially appreciated. She had varicosities in her right groin and thigh with pulsations visible as well as palpable. There were smaller varicosities in the left groin and thigh as well. No audible bruit was appreciated over the right femoral artery, and Branham's sign was not present.
Rather than performing arteriography to differentiate between tricuspid regurgitation and arteriovenous ®stula, we obtained a blood sample from a thigh varix for blood gas determination which unequivocally documented venous blood, obviating the need for the more invasive and costly arteriogram. The patient thereafter underwent excision of her varicosities. Blood gas determination is easily done, and does not require the expertise of a sonographer. Moreover, the cost of this test is much less than that of a duplex ultrasound examination. 
Age-related distortion
Dr Rohde (January 2000 JRSM, pp. 35±36) suggests that the phenomenon age-related distortion deserves a more formal name. Could I suggest`dysjuvemnesia', which, although not lightly tripping off the tongue, encapsulates the elements of memory impairment and its distortion, and also indicates its focus on the recall of youth. 
The two cultures of medicine
It is stimulating to read Professor Wulff's ideas on the application of`science and arts' to medical thinking (November 1999 JRSM, pp. 549±552). Having run a dental phobia clinic for more than 20 years, involving a rational approach utilizing dentistry, physiology, psychiatry, medicine; surgery, etc., I have found great dif®culty in communicating successful treatments to the specialists concerned. Each specialty has its own language and culture. If one does not use the`correct language or jargon' for each, evidence is dismissed. Specialties also differ in the application of scienti®c knowledge (e.g. recommendations for the use of heparin/warfarin) country to country, area to area. Will these differences disappear with the acceptance of evidence-based medicine and dentistry by the professions?
How do patients select their medical professionals? In dentistry, patients will travel many miles to a dentist they believe and trust (or is it the devil they know?). It is always useful to be reminded of the human condition and how dif®cult it is to achieve rapport.
Chris Wilks
King's Dental Institute, King's Healthcare NHS Trust, Caldecot Road, London SE5 9RW, UK
Tyger tyger
Anand Date cautions that continuing study of tiger injuries will be professionally unrewardingÐsince the aetiological agent is soon to be eradicated (March 2000 JRSM, p. 160). The International Herald Tribune of 17 March carries a report of a 3-year-old boy who lost part of his arm upon reaching into the cage of a pet Bengal tiger, in Harris County, Texas. The limb, which was torn off`between the shoulder and elbow,' was packed in ice and reattached in an 11-hour procedure at Memorial Hermann Children's Hospital. The outcome of the procedure was not stated. Notwithstanding his eloquent poetic allusion, Dr Date's counsel therefore appears premature. Nor, it would seem, can we yet afford 
